+
Site Tour

bRIGHT study 1-year data card

Brief outline of the 1-year data outcomes from the bRIGHT study evaluating the safety and effectiveness of TriClip™ TEER in patients with severe TR in a real-world, post-market setting.

Download

Related Resources

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

EuroPCR 2023: Vascular access

TAVI 2023: Calcified valve

Case Parade | Tricuspid focus

AV VALVES 2023: Staged, Concomitant

EACTS 2022: SMV repair vs replacement

Navitor™: Voice of the Experts Francesco Bedogni

Case Parade | Mitral focus

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

PCRLV 2022: bRIGHT 30 days

PCR LV 2021: Navitor™ 30-day outcomes

ESC 2022: FMR

PCR LV 2021: Navitor™ Live-in-a-box

CONNEXT


LIVE
RELATED EVENTS

Trending Controversies | AV Valves

TAVI Summit - Live case from Berlin

AV Valves Summit 2024 | Closing of Day 2

TAVI Case Club – Challenge of difficult access

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline